Aprepitant and Fosaprepitant: A 10‐Year Review of Efficacy and Safety
Aapro, Matti, Carides, Alexandra, Rapoport, Bernardo L., Schmoll, Hans‐Joachim, Zhang, Li, Warr, David
Published in The oncologist (Dayton, Ohio) (01.04.2015)
Published in The oncologist (Dayton, Ohio) (01.04.2015)
Get full text
Journal Article
Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials
Popovic, Marko, Warr, David G., DeAngelis, Carlo, Tsao, May, Chan, Kelvin K. W., Poon, Michael, Yip, Cheryl, Pulenzas, Natalie, Lam, Henry, Zhang, Liying, Chow, Edward
Published in Supportive care in cancer (01.06.2014)
Published in Supportive care in cancer (01.06.2014)
Get full text
Journal Article
Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy
Warr, David G., Street, James C., Carides, Alexandra D.
Published in Supportive care in cancer (01.06.2011)
Published in Supportive care in cancer (01.06.2011)
Get full text
Journal Article
Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis
Chow, Ronald, Warr, David G., Navari, Rudolph M., Tsao, May, Popovic, Marko, Chiu, Leonard, Milakovic, Milica, Lam, Henry, DeAngelis, Carlo
Published in Supportive care in cancer (01.08.2018)
Published in Supportive care in cancer (01.08.2018)
Get full text
Journal Article
Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings—a meta-analysis
Jordan, Karin, Warr, David G., Hinke, Axel, Sun, Linda, Hesketh, Paul J.
Published in Supportive care in cancer (01.05.2016)
Published in Supportive care in cancer (01.05.2016)
Get full text
Journal Article
Should palonosetron be a preferred 5-HT 3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis
Chow, Ronald, Warr, David G, Navari, Rudolph M, Tsao, May, Popovic, Marko, Chiu, Leonard, Milakovic, Milica, Lam, Henry, DeAngelis, Carlo
Published in Supportive care in cancer (01.08.2018)
Published in Supportive care in cancer (01.08.2018)
Get full text
Journal Article
Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy
WARR, David G, HESKETH, Paul J, BOHIDAR, Norman, KLINGER, George, HUSTAD, Carolyn M, HORGAN, Kevin J, SKOBIERANDA, Franck, GRALLA, Richard J, MUSS, Hyman B, HERRSTEDT, Jam, EISENBERG, Peter D, RAFTOPOULOS, Harry, GRUNBERG, Steven M, GABRIEL, Munir, RODGERS, Anthony
Published in Journal of clinical oncology (20.04.2005)
Published in Journal of clinical oncology (20.04.2005)
Get full text
Journal Article
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
HESKETH, Paul J, GRUNBERG, Steven M, EVANS, Judith K, BECK, Klaus, REINES, Scott, HORGAN, Kevin J, GRALLA, Richard J, WARR, David G, ROILA, Fausto, DE WIT, Ronald, CHAWLA, Sant P, CARIDES, Alexandra D, LANUS, Juliana, ELMER, Mary E
Published in Journal of clinical oncology (15.11.2003)
Published in Journal of clinical oncology (15.11.2003)
Get full text
Journal Article
Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
BORDELEAU, Louise, PRITCHARD, Kathleen I, LOPRINZI, Charles L, ENNIS, Marguerite, JUGOVIC, Olivera, WARR, David, HAQ, Rashida, GOODWIN, Pamela J
Published in Journal of clinical oncology (10.12.2010)
Published in Journal of clinical oncology (10.12.2010)
Get full text
Journal Article
2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents
Jordan, Karin, Chan, Alexandre, Gralla, Richard J., Jahn, Franziska, Rapoport, Bernardo, Warr, David, Hesketh, Paul J.
Published in Supportive care in cancer (01.01.2017)
Published in Supportive care in cancer (01.01.2017)
Get full text
Journal Article
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
Pezo, Rossanna C., Chen, Tom W., Berman, Hal K., Mulligan, Anna M., Razak, Albiruni A., Siu, Lillian L., Cescon, David W., Amir, Eitan, Elser, Christine, Warr, David G., Sridhar, Srikala S., Yu, Celeste, Wang, Lisa, Stockley, Tracy L., Kamel-Reid, Suzanne, Bedard, Philippe L.
Published in Breast cancer research and treatment (01.02.2018)
Published in Breast cancer research and treatment (01.02.2018)
Get full text
Journal Article
Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer
TCHEN, Nadine, JUFFS, Helen G, TWEEDALE, Mary E, TANNOCK, Ian F, DOWNIE, Fiona P, YI, Qi-Long, HANXIAN HU, CHEMERYNSKY, Irene, CLEMONS, Mark, CRUMP, Michael, GOSS, Paul E, WARR, David
Published in Journal of clinical oncology (15.11.2003)
Published in Journal of clinical oncology (15.11.2003)
Get full text
Journal Article
Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—state of the art
Grunberg, Steven M., Warr, David, Gralla, Richard J., Rapoport, Bernardo L., Hesketh, Paul J., Jordan, Karin, Espersen, Birgitte T.
Published in Supportive care in cancer (01.03.2011)
Published in Supportive care in cancer (01.03.2011)
Get full text
Journal Article
A Phase 2 study of perifosine in advanced or metastatic breast cancer
Leighl, Natasha B., Dent, Susan, Clemons, Mark, Vandenberg, Theodore A., Tozer, Richard, Warr, David G., Crump, R. Michael, Hedley, David, Pond, Gregory R., Dancey, Janet E., Moore, Malcolm J.
Published in Breast cancer research and treatment (01.03.2008)
Published in Breast cancer research and treatment (01.03.2008)
Get full text
Journal Article
Efficacy and tolerability of aprepitant for the prevention of chemotherapy‐induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy
Herrstedt, Jørn, Muss, Hyman B., Warr, David G., Hesketh, Paul J., Eisenberg, Peter D., Raftopoulos, Harry, Grunberg, Steven M., Gabriel, Munir, Rodgers, Anthony, Hustad, Carolyn M., Horgan, Kevin J., Skobieranda, Franck
Published in Cancer (01.10.2005)
Published in Cancer (01.10.2005)
Get full text
Journal Article
Acetaminophen (Paracetamol) Improves Pain and Well-Being in People With Advanced Cancer Already Receiving a Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial
STOCKLER, Martin, VARDY, Janette, PILLAI, Avinesh, WARR, David
Published in Journal of clinical oncology (15.08.2004)
Published in Journal of clinical oncology (15.08.2004)
Get full text
Journal Article
Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC)
Hesketh, Paul J., Warr, David G., Street, James C., Carides, Alexandra D.
Published in Supportive care in cancer (01.09.2011)
Published in Supportive care in cancer (01.09.2011)
Get full text
Journal Article
What Patients with Cancer Want to Know About Pain: A Qualitative Study
Bender, Jacqueline L., BSc, MSc, Hohenadel, Joanne, BHSc, Wong, Jennifer, BSc, Katz, Joel, PhD, Ferris, Lorraine E., PhD, LLM, Shobbrook, Cindy, RN, MN, ACNP, Warr, David, MD, Jadad, Alejandro R., MD, DPhil, FRCPC
Published in Journal of pain and symptom management (01.02.2008)
Published in Journal of pain and symptom management (01.02.2008)
Get full text
Journal Article